L
65
-3
EQT
44
-6
EXR
64
-2
AKAM
53
2
HP
52
2
PFE
28
2
NVDA
54
2
HRL
51
4
CMCSA
50
2
FLS
75
2
CCI
36
-2
AMGN
33
2
PEP
53
3
EL
30
-4
PSX
49
2
MTB
65
-3
KSS
26
3
DGX
44
-3
BXP
55
-4
ROK
56
-7
L
65
-3
EQT
44
-6
EXR
64
-2
AKAM
53
2
HP
52
2
PFE
28
2
NVDA
54
2
HRL
51
4
CMCSA
50
2
FLS
75
2
CCI
36
-2
AMGN
33
2
PEP
53
3
EL
30
-4
PSX
49
2
MTB
65
-3
KSS
26
3
DGX
44
-3
BXP
55
-4
ROK
56
-7
Financhill
Back

Texas Capital Bancshares Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
63

TCBI
Texas Capital Bancshares

Last Price:
88.44
Seasonality Move:
3.88%
Buy
58

SRPT
Sarepta Therapeutics

Last Price:
133.49
Seasonality Move:
14.88%
Buy
63
Texas Capital Bancshares (TCBI) is a Buy

Is Texas Capital Bancshares a Buy, Sell or Hold?

  • The current Texas Capital Bancshares [TCBI] share price is $88.45. The Score for TCBI is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • TCBI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $133.34. The Score for SRPT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TCBI Stock Price Chart

What is Texas Capital Bancshares's stock price today?

  • The Texas Capital Bancshares share price today is $88.45
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TCBI is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $133.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

TCBI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.98 Buy
Relative Strength Index (14 RSI): 63.45 Buy
Chaikin Money Flow: -148690 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (78.89 - 88.83) Buy
Bollinger Bands (100): (63.28 - 80.64) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.78 Buy
Relative Strength Index (14 RSI): 63.54 Buy
Chaikin Money Flow: -725343 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (110.85 - 129.81) Buy
Bollinger Bands (100): (119.21 - 141.67) Buy

TCBI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 87.4 Buy
20-day SMA: 85.48 Buy
50-day SMA: 78.82 Buy
200-day SMA: 65.6 Buy
8-day EMA: 87.91 Buy
20-day EMA: 85.42 Buy
50-day EMA: 79.88 Buy
200-day EMA: 68.68 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 119.83 Buy
20-day SMA: 118.14 Buy
50-day SMA: 122.33 Buy
200-day SMA: 130.09 Buy
8-day EMA: 123.82 Buy
20-day EMA: 120.48 Buy
50-day EMA: 122.96 Buy
200-day EMA: 126.17 Buy

Texas Capital Bancshares Earnings Growth & TCBI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $1.49 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.

Texas Capital Bancshares Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):